Global Xylo-oligosaccharides Market Overview
The key driver impacting the Xylo-oligosaccharides market is the growing popularity and consumption of Probiotics, prebiotics, and dietary supplements across the globe. For instance, According to the National Center for Complementary and Integrative Health (NIH), Probiotics or prebiotics were the third most commonly used dietary supplement other than vitamins and minerals among adults in the U.S. According to the Latin American Alliance for Responsible Nutrition 2016 report, around 71% of U.S. adults, or more than 170 million Americans, takes dietary supplements in their life. Moreover, the growing applications of Xylo-oligosaccharides in the field of dietary supplements and functional food and beverages are also estimated to be a key determinant that adds growth to the market. Whereas with regards to volume, the market was calculated XX Tons in 2019 and foreseen to grow with a CAGR of XX% during 2020-2026.
According to Value Market Research, the global Xylo-oligosaccharides market was valued at around USD 110 million in 2019 and is estimated to grow at a CAGR of about 12% during the forecast period of 2020-2026.
In addition to this, numerous health benefits associated with Xylo-oligosaccharides, such as anti-allergic, antioxidant, and anti-inflammatory, are anticipated to increase the Xylo-oligosaccharides market demand under the forecast period. The changing lifestyle leads to growing cases of obesity, diabetes, stress across the globe is also positively impacting the market. For instance, According to the International Diabetic Federation (IDF), there was approximately 463 million adults (20-79 years) were living with diabetes in the year 2019 and is expected to reach 700 million by 2045. Also, a health data organization report shows, there are around 2.1 billion people (that is 30% of the world’s population) who were, are either overweight or obese globally in 2015.
However, the high initial investment and costly equipment needed for production may hamper the global Xylo-oligosaccharides industry in the long run. The production of xylooligosaccharides produces unwanted products such as hydroxymethyl furfural in the XOS mixture, which can cause skin allergy, is likely to impact market growth negatively. The current industry trend, such as changing lifestyles and growing health concerns among consumers is expected to create new market opportunities for the key players in the coming years.
The Xylo-oligosaccharides market is vast, with a large number of local and global players. The key leaders follow various strategies to improve their market position, such as acquisitions, mergers, expansions, and product innovations to enhance their market share across the world. For instance, in April 2018, UAS Laboratories LLC acquired Nebraska Cultures, which is a neutraceuticals company. This acquisition helped UAS Laboratories LLC to expand its business line in the field of nutraceuticals. The dominating key players included in the report are Fengyuan Zhongke, Hebi Taixin, Hengfeng Sugar, Huaian Baimai Keyu, Kanwei Biologic, UAS Laboratories LLC, Longlive, Suntory,Suzhou Xiankuo, and Yatai. have always been the initial targets of Xylo-oligosaccharides companies and many others.
In this market research report, the market is segmented by type, applications, and region.
Analysis by Type:
By type, the report is categorized into XOS-95P, XOS-70P, XOS-50L, XOS-35P, and XOS-20P. XOS-95P and XOS-70P dominate the type segment in 2019, with over 30% market share. It is due to the food beverage industry majorly utilized XOS-95P and XOS-70P types as compared to others, which is driving the XOS-95P and XOS-70P type segment of the Xylo-oligosaccharides market in the forecast period.
Analysis by Applications:
By application, the report is categorized into nutraceuticals & pharmaceuticals, food & beverages, feed, and others. Nutraceuticals & Pharmaceuticals dominate the application segment in 2019 with a maximum market share of 50% in terms of revenue. It is due to the factors such as several advantages provided by XOS such as water-binding capacity, sweetening ability, and fat replacement value which make it suitable to be adopted by pharmaceuticals & nutraceuticals companies globally. Moreover, lots of health benefits associated with the xylooligosaccharides, such as anti-allergic, antioxidant, and anti-inflammatory, are driving the nutraceutical & pharmaceuticals segment of the Xylo-oligosaccharides market in the forecast period.
Analysis by Region:
In the regional outlook of the global Xylo-oligosaccharides market, the Asia Pacific region dominates with a maximum market share of 30% in 2019. It is anticipated to show huge growth in the forecast period due to the growing number of pharmaceutical industries and the rising prevalence of diabetes and obesity in the region. Moreover, and rapidly growing food and beverage sector across China, and India, contributes to the growth of the Xylo-oligosaccharides market in APAC.
Market Segmentation covered in the Report:
By Product Type
- Nutraceuticals & Pharmaceuticals
- Food & Beverages
- North America
- the Asia Pacific
- Latin America
- The Middle East and Africa
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.